Technical Analysis for ENSC - Ensysce Biosciences, Inc.

Grade Last Price % Change Price Change
F 0.72 0.69% 0.00
ENSC closed up 0.69 percent on Monday, February 6, 2023, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
New Uptrend Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish 0.69%
NR7 Range Contraction 0.69%
Narrow Range Bar Range Contraction 0.69%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 4 hours ago
20 DMA Resistance about 5 hours ago
10 DMA Resistance about 5 hours ago
Up 3% about 5 hours ago
Up 2% about 5 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder Substance Dependence

Is ENSC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.6
52 Week Low 0.5902
Average Volume 2,641,642
200-Day Moving Average 7.12
50-Day Moving Average 1.13
20-Day Moving Average 0.73
10-Day Moving Average 0.73
Average True Range 0.14
RSI 42.20
ADX 25.59
+DI 40.51
-DI 18.27
Chandelier Exit (Long, 3 ATRs) 1.10
Chandelier Exit (Short, 3 ATRs) 1.07
Upper Bollinger Bands 0.86
Lower Bollinger Band 0.61
Percent B (%b) 0.44
BandWidth 32.93
MACD Line -0.10
MACD Signal Line -0.14
MACD Histogram 0.0403
Fundamentals Value
Market Cap 4.51 Million
Num Shares 6.26 Million
EPS 0.11
Price-to-Earnings (P/E) Ratio 6.73
Price-to-Sales 0.00
Price-to-Book 12.49
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.78
Resistance 3 (R3) 0.78 0.76 0.77
Resistance 2 (R2) 0.76 0.74 0.76 0.77
Resistance 1 (R1) 0.74 0.74 0.74 0.74 0.76
Pivot Point 0.72 0.72 0.72 0.72 0.72
Support 1 (S1) 0.70 0.70 0.70 0.70 0.68
Support 2 (S2) 0.68 0.70 0.68 0.67
Support 3 (S3) 0.66 0.68 0.67
Support 4 (S4) 0.66